Saliva test could offer new way to check immunity

December 14, 2016

New research from the University of Birmingham shows that antibody levels in saliva are linked to those in blood serum, suggesting a new method for assessment of protection against bacterial infections.

For a study published in the journal Biomarkers, samples of both blood and saliva were taken from 72 healthy adults. Samples were then analysed to test for concentrations of IgG, IgM and IgA antibodies against 12 pneumococcal (Pn) antigens.

The researchers found that in general, higher antibody concentrations in serum were associated with higher concentrations in saliva, with the strongest relationships observed for IgA antibodies.

While these preliminary results cannot yet be used to inform clinical decisions at an individual level, they suggest that measuring antibodies in saliva may have promise in future epidemiological studies relating to vaccination against bacterial infections, particularly in developing countries.

Lead author, Dr Jennifer Heaney from the School of Immunity and Infection at the University of Birmingham, says:

'Protection against is usually inferred by measuring in . But taking samples involves a number of logistical considerations and may not always be feasible, especially in developing countries or where children are involved. Saliva sampling is non-invasive, requires no specialist training or equipment, and may be more cost-effective.

'The suggestion that antibody levels in saliva may be indicative of those in therefore has important implications for markers of immunity and vaccination in many parts of the world. This research highlights the need for larger studies further to investigate the potential of saliva testing as a tool to assess immunity.'

Previous research from the University of Birmingham showed that lower levels of antibodies in saliva are associated with of an elevated risk of mortality, and that sampling to determine IgA secretion rate has the potential to be used as an indicator of overall health by professionals as part of a general check-up.

Explore further: Levels of antibodies in saliva are associated with risk of mortality

More information: Jennifer L.J. Heaney et al, The utility of saliva for the assessment of anti-pneumococcal antibodies: investigation of saliva as a marker of antibody status in serum, Biomarkers (2016). DOI: 10.1080/1354750X.2016.1265009

Related Stories

Levels of antibodies in saliva are associated with risk of mortality

December 23, 2015
New research from the University of Birmingham has found that lower levels of antibodies in saliva are associated with of an elevated risk of mortality, and could be an early indicator of risk.

Mosquito saliva increases disease severity following dengue virus infection

June 16, 2016
Insects transmit diseases when, probing for blood vessels, they inject saliva together with viral, bacterial, or parasitic pathogens into the skin of mammalian hosts. A study in mice published on June 16, 2016 in PLOS Pathogens ...

Sandfly spit vaccinates mice against leishmaniasis infection

November 3, 2016
A vaccine against cutaneous leishmaniasis, a skin infection caused by Leishmania parasites, may be spitting distance away—sand fly spit, that is. Saliva from a species of the fly responsible for transmitting leishmaniasis ...

Antibody test gauges mosquito exposure

December 1, 2016
How many mosquitoes live in your neighborhood? How many mosquito bites have you and your neighbors gotten this week? Answering these questions—and gauging how mosquito populations change over time or after a control strategy ...

Review: methodological limitations for OSCC biomarkers

December 5, 2016
(HealthDay)—Methodological concerns have limited the analysis of saliva-based biomarkers for oral squamous cell carcinoma (OSCC), according to a review published online Nov. 29 in Head and Neck.

Recommended for you

Researchers discover key signaling protein for muscle growth

November 20, 2017
Researchers at the University of Louisville have discovered the importance of a well-known protein, myeloid differentiation primary response gene 88 (MyD88), in the development and regeneration of muscles. Ashok Kumar, Ph.D., ...

New breast cell types discovered by multidisciplinary research team

November 20, 2017
A joint effort by breast cancer researchers and bioinformaticians has provided new insights into the molecular changes that drive breast development.

Brain cell advance brings hope for Creutzfeldt-Jakob disease

November 20, 2017
Scientists have developed a new system to study Creutzfeldt-Jakob disease in the laboratory, paving the way for research to find treatments for the fatal brain disorder.

Hibernating ground squirrels provide clues to new stroke treatments

November 17, 2017
In the fight against brain damage caused by stroke, researchers have turned to an unlikely source of inspiration: hibernating ground squirrels.

Molecular guardian defends cells, organs against excess cholesterol

November 16, 2017
A team of researchers at the Harvard T. H. Chan School of Public Health has illuminated a critical player in cholesterol metabolism that acts as a molecular guardian in cells to help maintain cholesterol levels within a safe, ...

Prototype ear plug sensor could improve monitoring of vital signs

November 16, 2017
Scientists have developed a sensor that fits in the ear, with the aim of monitoring the heart, brain and lungs functions for health and fitness.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.